INTERDICT BIO, INC. – Trademark Portfolio

Entity Type: 03

INTERDICT BIO, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include INTERDICTIONARY. The owner is based in South San Francisco, CA.

201 Haskins Way

South San Francisco, CA 94080

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

INTERDICT BIO, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does INTERDICT BIO, INC. have?

INTERDICT BIO, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending, 1 abandoned.

What trademark classes does INTERDICT BIO, INC. file in?

INTERDICT BIO, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are INTERDICT BIO, INC.'s most well-known trademarks?

INTERDICT BIO, INC.'s registered trademark portfolio includes well-known marks such as INTERDICTIONARY. These are among 1 currently registered trademark in the portfolio.

What is INTERDICT BIO, INC.'s trademark registration success rate?

INTERDICT BIO, INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.